AMERCO is a holding company. The company is engaged as a moving and storage operator through its subsidiary U-Haul International, Inc. (U-Haul). The company's segments include: Moving and Storage, which consists of the rental of trucks, trailers, portable moving and storage units, specialty rental items and self-storage spaces to the household mover as well as sales of moving supplies, towing accessories and propane; Property and Casualty Insurance, which provides loss adjusting and claims handling for U-Haul; and Life Insurance, which provides life and health insurance products to the senior market through the direct writing and reinsuring of life insurance, Medicare supplement and annuity policies.

Beyond Air is a medical device company developing a nitric oxide (NO) generator and delivery system (the Beyond Air NOGDS) that is capable of generating NO from ambient air. The Beyond Air NOGDS can deliver NO either continuously or for a fixed amount of time at various flow rates and has the ability to either titrate dose on demand or maintain a constant dose. The company's initial areas of focus are persistent pulmonary hypertension of the newborn (PPHN), bronchiolitis and nontuberculous mycobacteria. With respect to PPHN, the company's Beyond Air NOGDS is designed to deliver a dosage of low-concentration of NO to the lungs. The company's Beyond Air NOGDS can also deliver a high concentration of NO to the lungs.

CNB Financial is a financial holding company. Through its subsidiary, CNB Bank, the company is engaged in banking activities and services for individual, business, governmental and institutional customers which include checking, savings, and time deposit accounts; real estate, commercial, industrial, residential and consumer loans; and other financial services. The company's other subsidiaries include: CNB Securities Corporation, which maintains investments in debt and equity securities; CNB Insurance Agency, which provides for the sale of nonproprietary annuities and other insurance products; and CNB Risk Management, Inc., which insures against certain risks to the operations of the company and its subsidiaries.

Core Molding Technologies operates in the composites market in a family of products known as structural composites. Structural composites are combinations of resins and reinforcing fibers (typically glass or carbon) that are molded to shape. The company is a manufacturer of sheet molding compound (SMC) and molder of thermoset and thermoplastic products. The company focuses on moldings and provides processes, including compression molding of SMC, glass mat thermoplastics, bulk molding compounds and direct long fiber thermoplastic, spray-up, hand-lay-up, resin transfer molding, structural foam and structural web injection molding, and reaction injection molding, utilizing dicyclopentadiene technology.

Dollar Tree is an operator of discount variety stores. The company's stores operate under the names of Dollar Tree, Family Dollar and Dollar Tree Canada. The company's segments are: Dollar Tree, which is the operator of discount variety stores providing merchandise at the fixed price point of $1.00; and Family Dollar, which operates general merchandise discount retail stores. The merchandise mix in the company's Dollar Tree stores consists of consumable merchandise, variety merchandise, and seasonal goods. The merchandise mix in the company's Family Dollar stores consists of consumable merchandise, home products, apparel and accessories merchandise, and seasonal and electronics merchandise.

DXP Enterprises is engaged in the business of distributing maintenance, repair and operating (MRO) products, equipment and service to energy and industrial customers. The company's segments include: Service Centers, which is engaged in providing MRO products, equipment and integrated services, including technical services and logistics capabilities, to energy and industrial customers with the ability to provide same day delivery; Supply Chain Services, which manages all or part of its customers' supply chains including procurement and inventory management; and Innovative Pumping Solutions, which provides custom pump skid packages, pump remanufacturing and manufactures branded private label pumps.

Entasis Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibacterial products to treat serious infections caused by multidrug-resistant Gram-negative bacteria. The company's lead product candidate, ETX2514, as well as one of its other product candidates, ETX0282, inhibit one of the most prevalent forms of bacterial resistance, ?-lactamase enzymes, so named because of their ability to inactivate ?-lactam antibiotics. The company's other product candidate, zoliflodacin, targets the validated mechanism of action of the fluoroquinolone class of antibiotics, but does so in a manner to avoid existing fluoroquinolone resistance.

Evofem Biosciences is a clinical-stage biopharmaceutical company committed to developing and commercializing products to address unmet needs in women's sexual and reproductive health. The company is utilizing its proprietary Multi-purpose Vaginal pH Regulator ? (MVP-R) platform to develop its product candidate, Amphora (L-lactic acid, citric acid, and potassium bitartrate), which is used for potential indications such as prevention of pregnancy, prevention of urogenital Chlamydia trachomatis infection in women and prevention of urogenital Neisseria gonorrhoeae infection in women. The company is also developing its MVP-R gel product candidate for the treatment of recurrent bacterial vaginosis.

First Bancorp is a bank holding company. Through its subsidiary, First Bank, the company is engaged in a range of banking activities, with the acceptance of deposits and the making of loans being its basic activities. The company provides deposit products such as checking, savings, and money market accounts, as well as time deposits, including various types of certificates of deposits and individual retirement accounts. The company provides loans for a range of consumer and commercial purposes, including loans for business, real estate, personal uses, home improvement and automobiles. The company also provides credit cards, debit cards, letters of credit, safe deposit box rentals and electronic funds transfer services.

First Guaranty Bancshares is a bank holding company. The company, through its subsidiary, First Guaranty Bank (the Bank), provides a range of financial services to consumers and businesses in the communities in which it operates. These services include consumer and commercial lending, mortgage loan origination, the issuance of credit cards and retail banking services. The Bank also maintains an investment portfolio comprised of government, government agency, corporate, and municipal securities. The company's key market areas include the Louisiana Market Services Areas (MSAs) of Hammond, Baton Rouge, Lafayette, and Shreveport-Bossier City along with the Texas MSAs of Dallas-Fort Worth-Arlington and Waco.

Franklin Financial Services is a bank holding company. Through its banking subsidiary, Farmers and Merchants Trust Company of Chambersburg (the Bank), the company is engaged in general commercial, retail banking and trust services. The Bank's lending activities consist primarily of commercial real estate, construction and land development, agricultural, commercial and industrial loans, installment and revolving loans to consumers and residential mortgage loans. The Bank also provides various deposit products including demand deposits (noninterest and interest-bearing accounts), savings, money management accounts, and time deposits (certificates of deposits).

Golub Capital BDC is registered as an externally managed, closed-end, non-diversified management investment company. The company makes investments primarily in one stop (a loan that combines characteristics of first lien senior secured loans and second lien or subordinated loans) and other senior secured loans of middle-market companies that are, in most cases, sponsored by private equity firms. The company's investment objective is to generate existing income and capital appreciation by investing primarily in one stop and other senior secured loans of United States middle-market companies.

i3 Verticals is a holding company. Through its subsidiaries, the company provides integrated payment and software solutions to small-and medium-sized businesses and organizations in vertical markets. The company's payment processing services enable clients to accept electronic payments, facilitating the exchange of funds and transaction data between clients, financial institutions and payment networks. The company has two reportable segments: Merchant Services, which provides payment solutions to businesses and organizations; and Proprietary Software and Payments, which provides embedded payment solutions to its clients through company-owned software.

Idera Pharmaceuticals is a biopharmaceutical company focused on the clinical development and commercialization of drug candidates for both oncology and rare disease indications. The company's focus is on its Toll-like receptor (TLR), agonist, tilsotolimod (IMO-2125), for oncology. The company is developing tilsotolimod, via intratumoral injection, for the treatment of anti-PD1 refractory metastatic melanoma in combination with ipilimumab, an anti-CTLA4 antibody marketed as Yervoy? by Bristol-Myers Squibb Company (BMS). The company is also evaluating intratumoral tilsotolimod in combination with nivolumab, an anti-PD1 antibody marketed as Opdivo? by BMS, and ipilimumab for the treatment of multiple solid tumors.

MacroGenics discovers and develops antibody-based therapeutics to modulate the human immune response for the treatment of cancer. The company has a pipeline of product candidates in human clinical testing, including immuno-oncology programs, that have been created using its proprietary antibody-based technology platforms. The company is developing product candidates that target various tumor-associated antigens, including HER2. The company is also developing a franchise of molecules that target programmed cell death protein 1 (PD-1). The company is developing two bispecific DART product candidates that engage PD-1 and lymphocyte-activation gene 3, as well as PD-1 and cytotoxic T-lymphocyte-associated protein 4.

National Bankshares is a financial holding company. Through its bank subsidiary, the National Bank of Blacksburg, the company provides a range of retail and commercial banking services to individuals, businesses, non-profits and local governments from its branch offices throughout southwest Virginia and a loan production office in Roanoke, VA. Loan types include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity and various consumer loan products. The company's subsidiary, National Bankshares Financial Services, Inc., provides non-deposit investment products and insurance products for sale to the public.

NeuroMetrix develops and commercializes health care products that utilize non-invasive neurostimulation and digital medicine. The company designs, builds and markets medical devices that stimulate nerves and analyzes nerve response for diagnostic and therapeutic purposes. The company's products consist of a medical device used in conjunction with a consumable electrode or biosensor. The company's marketed products include: DPNCheck, which is a nerve conduction test that is used to evaluate systemic neuropathies such as diabetic peripheral neuropathy; Quell, which is a wearable device for symptomatic relief of chronic pain; and ADVANCE System, which is a platform for the performance of nerve conduction studies.

New York Community Bancorp is a multi-bank holding company. Through its subsidiary, New York Community Bank, the company operates through eight local divisions: Queens County Savings Bank, Roslyn Savings Bank, Richmond County Savings Bank, Roosevelt Savings Bank, and Atlantic Bank in New York; Garden State Community Bank in New Jersey; Ohio Savings Bank in Ohio: and AmTrust Bank in Florida and Arizona. The company is also a producer of multi-family loans in New York City, with a focus on non-luxury residential apartment buildings with rent-regulated units that feature below-market rents.

Nicholas Financial is a holding company. Through its subsidiary, Nicholas Financial, Inc., the company is engaged primarily in acquiring and servicing automobile finance installment contracts (Contracts) for purchases of used and new automobiles and light trucks. In addition, the company also originates direct consumer loans (Direct Loans) and sells consumer-finance related products. For Automobile Finance Business - Contracts, the company is engaged in the business of providing financing programs, on behalf of purchasers of used cars and light trucks. For Contract Procurement, the Contracts purchased by the company is for used vehicles. For Direct Loans, the loans originated directly between the company and the consumer.

PDS Biotechnology is a clinical stage immuno-oncology company with a pipeline of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. All of the company's products are based on the proprietary Versamune? platform technology, which activates and directs the human immune system against cancer cells.

Preformed Line Products is a designer and manufacturer of products and systems employed in the construction and maintenance of overhead and underground networks for the energy, telecommunication, cable operators, and information industries. The company's products include: energy products, which support, protect, terminate and secure power conductor and communication cables and control cable dynamics; communications products, which protect fixed line communication networks from moisture, environmental hazards and other potential contaminants; and special industries products, which are used by energy, renewable energy, communications, cable and special industries for various applications.

ProPhase Labs is engaged in the research, development, manufacture, distribution, marketing and sale of over-the-counter (OTC) consumer healthcare products, dietary supplements and other remedies, including the development and marketing of dietary supplements under the TK Supplements? brand. The company's subsidiary, Pharmaloz Manufacturing Inc., is a manufacturer and distributor of non-GMO, organic and/or natural-based cough drops and lozenges and OTC drug and dietary supplement products. The company's TK Supplements? product line includes Legendz XL?, a male sexual enhancement, Triple Edge XL?, an energy and stamina booster, and Super Prostaflow+?, a supplement to support prostate and urinary health.

R. R. Donnelley & Sons is a communications provider. The company's segments are: Business Services and Marketing Solutions. The company's Business Services segment provides solutions to help clients inform, service and transact with their customers. Its products and services include commercial print, logistics, packaging, statement printing, labels, supply chain management, forms and business process outsourcing. The company's Marketing Solutions segment utilizes data analytics, creative services and multichannel execution to deliver end-to-end solutions. Its products and services include direct marketing, in-store marketing, digital print, kitting, fulfillment, digital and creative solutions and list services.

REV Group is a holding company. Through its subsidiaries, the company is a designer, manufacturer and distributor of specialty vehicles and related aftermarket parts and services. The company provides customized vehicle solutions for applications including: essential needs (ambulances, fire apparatus, school buses and municipal transit buses), industrial and commercial (terminal trucks, cut-away buses and sweepers) and consumer leisure (recreational vehicles (RVs), and coaches). The company's segments are: Fire and Emergency, which sells fire apparatus equipment and ambulances; Commercial, which produces buses, terminal trucks and sweepers; and Recreation, which provides motorized and towable RV models.

RumbleON is a development stage company. The company is engaged in developing a capital light e-commerce platform facilitating the ability of both consumers and dealers to Buy-Sell-Trade-Finance pre-owned recreation vehicles in one online location. Serving both consumers and dealers, through its online marketplace platform, the company makes cash offers for the purchase of pre-owned vehicles. In addition, the company provides an inventory of pre-owned vehicles for sale along with third-party financing and associated products. The company utilizes regional partners in the acquisition of pre-owned vehicles to provide inspection, reconditioning and distribution services.

Sage Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing medicines to treat life-altering central nervous system disorders. The company's principal product candidate is ZULRESSO? (brexanolone) injection, a proprietary intravenous formulation of brexanolone for the treatment of postpartum depression (PPD). The company's other product candidate is SAGE-217, an oral compound that is being developed for PPD and major depressive disorder. The company also has a portfolio of other compounds that target GABAA receptors, which include SAGE-324 and SAGE-689. The company's second area of focus is the development of compounds that target the NMDA receptor, which include SAGE-718.

Venus Concept is a medical technology company developing and commercializing a robotic device, the ARTAS? System, that assists physicians in performing tasks that are a part of a follicular unit extraction surgery. The ARTAS? System includes the ARTAS Hair Studio application, a three-dimensional patient consultation tool that enables a physician to create a simulated hair transplant model for use in patient consultations. The ARTAS? System is comprised of the patient chair, the cart, which includes the robotic arm, vision system, artificial intelligence algorithms and a series of proprietary end effectors, which are the various devices at the end of the robotic arm.

Viking Therapeutics is a biopharmaceutical company focused on the development of therapies for metabolic and endocrine disorders. The company's main clinical program's drug candidate, VK2809, is an orally available, tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta in development for patients with non-alcoholic fatty liver disease and elevated low-density lipoprotein cholesterol. The company's second clinical program's primary drug candidate, VK5211, is an orally available, non-steroidal selective androgen receptor modulator in development for patients recovering from non-elective hip fracture surgery. The company is also developing VK0214 for X-linked adrenoleukodystrophy.